Anlon Healthcare: Intimation of receipt of 'In-Principle' Approval
Anlon Healthcare (AHCL) filed a disclosure titled "Intimation of receipt of 'In-Principle' Approval". The company is valued at about ₹1,335 crore.
What happened
Anlon Healthcare (AHCL) filed a disclosure with the exchanges on 29 October 2026 at 05:09 PM titled "Intimation of receipt of 'In-Principle' Approval".
Company snapshot
Anlon Healthcare is a small-cap company, with a market value of about ₹1,335 crore.
The stock last traded at ₹25.11, against a 52-week range of ₹10.37–₹37.24 (32.6% below the high).
Before this filing the shares had moved −22.3% over the month and +54.1% over three months. Average daily turnover over the last 20 sessions was about ₹26.47 crore.
Promoters held 52.68% at the end of Q1 FY27. Foreign institutions owned 1.67% and domestic institutions 1.22%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 33 | 3.5 | 2.22 |
| Q2 FY26 | 52 | 9.3 | 2.22 |
| Q3 FY26 | 36 | 5.2 | 1.13 |
| Q4 FY26 | 51 | 10.5 | 2.33 |
| Q1 FY27 | 88 | 8.3 | 0.16 |
What history shows
BCEIE has no earlier approval filing from this company on record since May 2026.
Market-wide, 1,527 approval filings with an impact score of 50 or more saw an average next-day move of +0.1%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
Market reaction so far
Since the filing, the stock has risen 2.6%, from ₹24.47 before the disclosure to ₹25.11 (last close).
What to watch
- 29 October 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.